Keyphrases
Lymphoma
100%
MicroRNA Profiling
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Hodgkin Lymphoma
100%
Lymphoma Patients
100%
Plasma microRNA
100%
Relapsed Lymphoma
66%
Plasma Parameters
66%
P53 Pathway
66%
MiR-122
66%
MiR-93
66%
P13K
33%
Healthy Adults
33%
Transforming Growth Factor-β
33%
Early Detection
33%
MicroRNA
33%
Dysregulated
33%
Potential Analysis
33%
Path Analysis
33%
High Mortality
33%
Early Relapse
33%
Survival Analysis
33%
MiRNA Target
33%
Sensitive Biomarker
33%
Small RNA Sequencing
33%
Clinical Relapse
33%
Therapy Response
33%
MiR-145
33%
MiR-30a
33%
MiR-20a
33%
MiR-23a
33%
MiR-26a
33%
MiR-141
33%
MiR-125b
33%
MiR-124
33%
MiR-182
33%
Identified Set
33%
Circulating microRNA
33%
MiR-25
33%
MiR-144
33%
MiR-532-5p
33%
MiR-425
33%
MiR-128
33%
MiR-106b-5p
33%
MiR-424
33%
MiR-197
33%
MiR-140
33%
MiR-186
33%
MiR-345
33%
Working Diagnosis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
microRNA
100%
Diffuse Large B Cell Lymphoma
100%
Hodgkin Disease
100%
Protein P53
66%
microRNA 122
66%
Normal Human
33%
RNA-Sequencing
33%
microRNA 141
33%
microRNA 182
33%
microRNA 124
33%
microRNA 20a
33%
microRNA 145
33%
Protein Kinase B
33%
Neuroscience
MicroRNA
100%
B Cell
100%
Blood Plasma
100%
P53
66%
microRNA 122
66%
STAT3
33%
Cyclic Adenosine Monophosphate
33%
Protein Kinase B
33%
Survival Analysis
33%
microRNA 20a
33%
RNA Sequence
33%
microRNA 182
33%
microRNA 124
33%
microRNA 141
33%
Mir-145
33%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
B Cell
100%
Blood Plasma
100%
Blood Level
66%
P53
66%
Normal Human
33%
RNA Sequence
33%
Upregulation
33%
down Regulation
33%
STAT3
33%
Cyclic Adenosine Monophosphate
33%
Protein Kinase B
33%
Mir-145
33%
Small RNAs
33%
Immunology and Microbiology
Blood Plasma
100%
B Cell
100%
Blood Level
66%
P53
66%
Normal Human
33%
RNA Sequence
33%
down Regulation
33%
Upregulation
33%
STAT3
33%